Gregory R. Sondag

发表

Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

K. Novak, Nagat A Frara, F. Safadi, 2014, The American journal of pathology.

Osteoactivin Induces Transdifferentiation of C2C12 Myoblasts Into Osteoblasts

Douglas C. Crowder, F. Safadi, Samir M. Abdelmagid, 2014, Journal of cellular physiology.

Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells

M. Oyewumi, Dharani Manickavasagam, K. Novak, 2016, Oncotarget.

Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function*

Bing Yu, Christopher Malcuit, K. Novak, 2015, The Journal of Biological Chemistry.

Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo

M. Barbe, S. Popoff, Nagat A Frara, 2016, Journal of cellular physiology.

A Novel Hybrid‐Structured Titanium Surface Promotes Adhesion of Human Dermal Fibroblasts and Osteogenesis of Human Mesenchymal Stem Cells while Reducing S. epidermidis Biofilm Accumulation

Byung-Wook Park, Christopher Malcuit, C. Lambert, 2016 .

The Role of MicroRNAs and Their Targets in Osteoarthritis

T. Haqqi, Gregory R. Sondag, 2016, Current Rheumatology Reports.

The role of miR-150 regulates bone cell differentiation and function.

F. Safadi, F. Moussa, Gregory R. Sondag, 2020, Bone.

Osteoactivin Promotes Osteoblast Adhesion Through HSPG and αvβ1 Integrin

Nagat A Frara, F. Safadi, Samir M. Abdelmagid, 2014, Journal of cellular biochemistry.

Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling

W. Geldenhuys, K. Novak, F. Safadi, 2016, Experimental & Molecular Medicine.

Macrophage‐Associated Osteoactivin/GPNMB Mediates Mesenchymal Stem Cell Survival, Proliferation, and Migration Via a CD44‐Dependent Mechanism

Christopher Malcuit, F. Safadi, Gregory R. Sondag, 2016, Journal of cellular biochemistry.

Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer.

W. Geldenhuys, P. Lockman, F. Safadi, 2017, Current cancer drug targets.

Macrophage‐Associated Osteoactivin/GPNMB Mediates Mesenchymal Stem Cell Survival, Proliferation, and Migration Via a CD44‐Dependent Mechanism

Christopher Malcuit, F. Safadi, Gregory R. Sondag, 2016, Journal of cellular biochemistry.

Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

K. Novak, F. Safadi, Samir M. Abdelmagid, 2014, American Journal of Pathology.